Search

Humana Inc

Gesloten

SectorGezondheidszorg

385.45 0.31

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

380.9

Max

385.85

Belangrijke statistieken

By Trading Economics

Inkomsten

-491M

693M

Verkoop

1.2B

41B

K/W

Sectorgemiddelde

38.507

56.432

EPS

7.61

Dividendrendement

0.86

Winstmarge

1.696

Werknemers

67,060

EBITDA

-658M

1.3B

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+10.44% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.86%

2.27%

Volgende Winsten

4 nov 2026

Volgende dividenddatum

27 nov 2026

Volgende Ex Dividend datum

30 sep 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.1B

49B

Vorige openingsprijs

385.14

Vorige sluitingsprijs

385.45

Nieuwssentiment

By Acuity

17%

83%

8 / 339 Rangschikking in Healthcare

Humana Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 sep 2026, 19:03 UTC

Humana Inc shares fell sharply, continuing a downward trend and remaining below their 20-day moving average amid ongoing market challenges.

15 sep 2026, 22:36 UTC

Humana Inc shares are trading lower in after-market hours, continuing a trend of three consecutive daily declines amid rising Treasury yields and inflation concerns.

11 sep 2026, 20:08 UTC

Humana Inc's shares are higher today, continuing a strong upward trend since Thursday. The stock remains above its 20-day moving average.

9 sep 2026, 20:02 UTC

Correlated Moves

Humana Inc shares are lower amid a broader market downturn and a decline in the Managed Health Care sector. Rising crude oil prices raise inflation concerns.

8 sep 2026, 19:46 UTC

News

Humana Inc. is under investigation by Bronstein, Gewirtz & Grossman, LLC, prompting investors to reassess their positions as shares trade higher since Friday.

3 sep 2026, 20:07 UTC

News

Humana Inc has earned the 2026 Great Place To Work Certification, contributing to positive investor sentiment as shares advance during Thursday's session.

2 sep 2026, 20:08 UTC

News

Humana Inc. shares are advancing as the company declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026.

1 sep 2026, 20:01 UTC

News
Event

Humana Inc. reaffirmed its fiscal year 2026 guidance, projecting at least $9 adjusted EPS, contributing to a positive market reaction and higher shares.

27 aug 2026, 19:46 UTC

News

Humana has partnered with DaVita to enhance care for Medicare Advantage members with chronic kidney disease. Shares are advancing amid positive market sentiment.

26 aug 2026, 20:08 UTC

Humana Inc shares are higher today amid mixed market performance and inflation data showing a slight consumer price increase in July.

25 aug 2026, 22:02 UTC

Humana Inc shares are higher in after-market hours, rebounding from session lows despite a broader market pullback and declining consumer confidence.

24 aug 2026, 20:06 UTC

News

Wolfe Research raised Humana's price target to $450, maintaining an Outperform rating. Shares are higher today, reflecting positive sentiment from the upgrade.

21 aug 2026, 19:31 UTC

Humana Inc. shares are advancing, reflecting a broader rebound in U.S. stocks amid ongoing economic uncertainties. They pulled back earlier but regained momentum.

20 aug 2026, 19:36 UTC

News

Humana Inc. appointed Dr. Shantanu Nundy as Chief Medical Officer, effective August 31. Shares are higher since Wednesday's close amid this leadership change.

19 aug 2026, 19:51 UTC

News

Humana Inc. shares are lower, impacted by a significant decline in the Managed Health Care sub-sector. The company continues expanding its home-based care initiative.

18 aug 2026, 19:16 UTC

Humana Inc shares are lower amid broader market weakness and rising U.S. Treasury yields, despite an earlier recovery during the session.

14 aug 2026, 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

12 aug 2026, 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

10 aug 2026, 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

7 aug 2026, 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

6 aug 2026, 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

5 aug 2026, 19:56 UTC

News
Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

4 aug 2026, 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

3 aug 2026, 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

31 jul 2026, 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

30 jul 2026, 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

29 jul 2026, 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

28 jul 2026, 23:16 UTC

News
Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

27 jul 2026, 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

24 jul 2026, 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

Peer Vergelijking

Prijswijziging

Humana Inc Prognose

Koersdoel

By TipRanks

10.44% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 426.524 USD  10.44%

Hoogste 624 USD

Laagste 280 USD

Gebaseerd op 23 Wall Street-analisten die 12-maands prijsdoelen bieden voor Humana Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

23 ratings

11

Buy

11

Hold

1

Sell

Sentiment

By Acuity

8 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.